InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: MacroEconTom post# 34201

Thursday, 11/11/2021 8:59:30 PM

Thursday, November 11, 2021 8:59:30 PM

Post# of 42715

has management ever come out and said this is different from rolling review?


Humanigen today announced its submission for Marketing Authorization for lenzilumab in COVID-19, begun in June 2021, has been accepted by the United Kingdom’s (UK’s) Medicines and Healthcare Products Regulatory Agency (MHRA) for expedited COVID-related rolling review, with assessment expected to occur more rapidly than a standard rolling review.

https://ir.humanigen.com/English/news/news-details/2021/UKs-MHRA-accepts-Humanigens-submission-of-Lenzilumab-for-Marketing-Authorization-in-COVID-19-for-expedited-rolling-review/default.aspx